Dr. Funke received her Ph.D. from the University of Würzburg, Germany and trained as a postdoctoral fellow at the Albert Einstein College of Medicine where she identified the gene for 22q11 deletion syndrome. She is Board certified in Clinical Molecular Genetics, served as Associate Professor of Pathology at Harvard Medical School where she was among the first worldwide to implement clinical NGS in 2011 at the Laboratory for Molecular Medicine in Cambridge.
In addition, Dr. Funke is known for leading international efforts to develop professional standards and guidelines for clinical genomic knowledge curation as well as development and validation of clinical genomic tests.
Today, Dr. Funke is Associate Professor at the Icahn School of Medicine at Mount Sinai and Vice President of Genomic Health at Sema4. Her long-term goal is to help increase the use genomic testing in clinical care, especially for disease prevention.